The well-known family of NF-B/Rel transcription factors is a children was 6.25 years at diagnosis, ranging from 5 days to central regulator of growth, differentiation and apoptosis in 17.75 years. As shown in Table 1 agarose gels and transferred on to nylon membrane. For
hybridization the following cDNA probes were used: a 950 bp EcoRI-AflIII fragment of NF-B2 12 containing exons 2 to 13 (exons 1a and 1b are non-coding), 10 ,13 a 1 kb EcoRI-EcoRV NF-B/Rel proteins comprise an ubiquitously expressed family fragment of c-Rel including exons 0 to 5, 7 and a 1.4 kb full of transcription factors which are important regulators of the length Bcl3 c-DNA. 5 Schemes of the NFKB2, 8, 10, 13 cREL, 7, 14, 15 immune function, acute phase response, growth and differenand BCL3 loci 5, 16 are shown in Figure 1a , b and c, respecttiation of hematopoietic cells. 1 More recently it became eviively. Hybridization and washing were carried out under strindent that NF-B is also a major regulator of apoptosis. 2, 3 There gent conditions. High molecular weight DNA from PB cells is an increasing number of reports, which suggest that NFof healthy donors were used as controls. Southern blot analy-B/Rel proteins are involved in the development of human sis of EcoRI digested genomic DNA of all 140 patients with cancer, especially hematopoietic malignancies (reviewed in different subtypes of childhood ALL showed germline conRef. 4 ). Structural alterations and chromosomal rearrangefiguration of the nfkb2, c-rel and bcl3 genes, respectively ments of three family members, bcl3, c-rel and nfkb2, have ( Figure 2 ). Additional Southern blot analysis of BamHI and been described in hematopoietic malignancies. The bcl3 gene HindIII digested DNA confirmed these results. was cloned out of the translocation t(14;19)(q32;q13) found Rearrangements in the nfkb2 gene were originally described in patients with B cell chronic lymphocytic leukemia. 5 This by Neri et al 9 by cloning the breakpoint junctions of a result in transcriptional up-regulation of bcl3. Involvement of t(10;14)(q24;q23) chromosomal translocation. Analysis of bcl3 in this translocation was confirmed, but is a rare abnorsequences adjacent to this breakpoint led to the identification mality in chronic lymphoproliferative disorders. 6 Alterations of lyt-10, which is identical to nfkb2. 9 To determine whether of the c-rel oncogene was shown in human non-Hodgkin's structural alterations of the NFKB2 (LYT10) locus were present lymphoma. 7 The chromosomal location of nfkb2 was assigned in other lymphoid malignancies, the authors included 38 to chromosome 10q24, a region which is associated with cases of non-Hodgkin's lymphoma and 49 cases of chronic translocations in T cell acute lymphoblastic leukemia and B lymphocytic leukemia in their study. Southern blot analysis cell non-Hodgkin's lymphoma. 8 In fact, nfkb2 is involved in using the same restriction digests and an almost identical the t(10;14)(q24;q32) of B cell non-Hodgkin's lymphoma. 9 cDNA probe as in our study identified two additional cases While the unprocessed form of NF-B2 is localized in the with rearrangements in the nfkb2 gene. Neri et al 9 used a cytoplasm, this rearrangement leads to a truncation of the C-855 bp EcoRI-StuI fragment spanning exons 3 to 14, comterminus and to a subsequent translocation of a constitutively pared to a 950 bp EcoRI-EcoRV probe containing the same active protein into the nucleus. Similar genomic alterations exons in our study. In the previous study, genomic DNA was are found in cutaneous T cell lymphomas. 10 digested with EcoRI and BamHI; we used EcoRI, BamHI and This study was undertaken to determine the incidence of in addition a HindIII restriction digest. Since the entire NFKB2 structural alterations of the nfkb2, c-rel, and bcl3 genes in the locus is contained in a single 18 kb EcoRI or a single 12 kb most frequent pediatric malignancy, acute lymphoblastic BamHI fragment, 9,10 any rearrangement affecting this region leukemia (ALL).
should have been detected by the restriction digests and probe After informed consent cell samples were obtained from used in the present study. 140 children with ALL enrolled in the multicenter ALL trials
The bcl3 gene contains 9 exons, spanning 11.5 kb. 16 Using ALL/NHL-BFM 86 and AL-BFM 90 of the German Berlina full length cDNA probe and genomic DNA digested with Frankfurt-Mü nster (BFM) study group. The mean age of the EcoRI we detected a 15 kb and a 6 kb band spanning the entire BCL3 locus. bcl3 was identified adjacent to the breakpoints in the translocation t(14;19)(q32;q13.1) recurrently 
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Figure 1
Schematic representations of the human (a) NFKB2, 8, 10, 13 (b) cREL 7, 14, 15 and (c) BCL3 loci. 5, 16 Exons are illustrated as boxes. Restriction sites for EcoRI (RI), BamHI (B) and HindIII (H) are indicated. apparent major transcription initiation site resulting in an updescribed, which resulted in increased expression of c-rel mRNA. Genomic DNA was digested with EcoRI and a fullregulation of bcl3 transcription. 5 Similar classical t(14;19)(q32;q13) rearrangements would have been detected length v-rel probe was used. 17 A similar genomic alteration would have been detected in our study. in our study. However, we cannot exclude more complex three-way rearrangements as recently reported t (7;19;14) The lack of detectable structural alterations of the nfkb2, crel or bcl3 genes in this study suggests that these genes play (q21;q13;q32), which were only detected by a long-range restriction mapping and would have been missed by Southern a minor role in childhood ALL despite involvement in other hematopoietic malignancies. blot analysis with the usually available BCL3 probes. 6 However, it is not clear whether these rearrangements affected expression levels of Bcl3. Previously, rearrangements in the REL locus were detected using genomic DNA digested with Acknowledgements BamHI, PvuII or NdeI and a genomic probe containing most of exon 4 and all of exon 5. 7 The detected BamHI fragment contains exons 3, 4, 5, 6a, 6a′, 6b and 7. Since exon 6a conThis work was supported by grants from the Klinikumsvorstand der Universitä t Ulm (Baustein P169) and the Deutsche tains an Alu repeat 14 we decided to use a cDNA probe spanning from exon 0 to 5 to avoid cross-hybridization with other Forschungsgemeinschaft (Sonderforschungsbereich 322, Teilprojekt A15). We gratefully acknowledge the close co-operAlu repeats. BamHI restriction digests in combination with this cDNA probe are suitable to detect all rearrangements so far ation with the participants of the BFM-ALL trials, especially Professor WD Ludwig for immunophenotypic characterizdescribed in human malignancies. In an avian B cell lymphoma cell line an insertion in the c-rel promoter region was ation.
